<?xml version="1.0" encoding="UTF-8"?>
<p>The World Health Organization (WHO) and federal agencies are largely focused on clinical trials for preapproved drugs that are proposed to target some aspect of the viral life cycle described above (
 <xref rid="fig1" ref-type="fig">Figure 
  <xref rid="fig1" ref-type="fig">1</xref>
 </xref>). The NIH now lists over a thousand ongoing clinical trials for treatments relating to COVID-19. The WHO is currently conducting a worldwide trial (“SOLIDARITY”) by focusing on four promising COVID-19 treatments: remdesivir; lopinavir/ritonavir with and without Interferon β-1a (to help stimulate the immune system); and hydroxychloroquine (this last treatment has currently been paused).
</p>
